BD Ultra-Fine Insulin Syringe 0.5mL Recalled for Nonsterility Risk
Becton Dickinson is recalling approximately 1.1 million BD Ultra-Fine Insulin Syringes due to nonsterility concerns. The affected syringes may expose patients to pathogenic microorganisms and risk of local infection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a sterile medical device (insulin syringe) with no reported illnesses or injuries, but presenting risk of infection from nonsterility. Per the severity rubric, risk-of-harm products where injury has not yet been reported score as High (3).
Plain-English summary
Becton Dickinson & Company has recalled approximately 1.1 million BD Ultra-Fine Insulin Syringe 0.5mL units (Catalog Number 326713) due to nonsterility concerns. The affected syringes may expose users to pathogenic microorganisms and pose a risk of local infection at the injection site.
The recall affects syringes distributed worldwide, including throughout the United States and in Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, and Canada. Three specific lot numbers are affected: 2038580, 2063298, and 2137904, all with expiration dates in May or July 2027.
No illnesses or injuries have been reported as of this recall notice. Patients who have used or have in their possession syringes from the affected lots should consult their healthcare provider. Those with affected syringes are advised to stop using them and contact Becton Dickinson or their healthcare provider for guidance on obtaining replacement syringes.
The recalled product
- Product
- BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326713
- Manufacturer
- Becton Dickinson & Company
- Category
- Medical Device — Insulin
- Affected units
- 1,129,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- GTIN: N/A Lot Number: 2038580
- Exp. Date: 20270531
- Lot Number: 2063298
- Lot Number: 2137904
- Exp. Date: 20270731
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Becton Dickinson & Company under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Becton Dickinson & Company
See all →- SevereBD Quincke spinal trays recalled over Huons bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 24 gauge spinal trays recalled over bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 22G spinal trays recalled in Huons bupivacaine sub-recall
FDA (Devices) · 2026-06-10
- SevereBD Whitacre spinal trays across nine catalog numbers recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD spinal trays recalled as a sub-recall of Huons bupivacaine
FDA (Devices) · 2026-06-10
Same hazard · nonsterile
See all →- HighBD Ultra-Fine Insulin Syringes Recalled Due to Nonsterile Condition
FDA (Devices) · 2023-03-22
- HighBD Ultra-Fine Insulin Syringe Recall Due to Nonsterile Manufacturing
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled for Sterility Defect
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled for Nonsterile Condition and Infection Risk
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled Due to Nonsterile Condition
FDA (Devices) · 2023-03-22